Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07369765 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Drug-Coated Balloon Versus Drug-eluting Stent Angioplasty for Treatment of Chronic Total Occlusion - The DCB-CTO Trial

Study acronym: DCB-CTO
StatusRecruiting
PhaseNot applicable
Started2025-08-28
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 27, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Chronic total occlusion (CTO) remains one of the most challenging lesions in coronary artery disease management. Percutaneous coronary intervention using drug-eluting stents is currently a standard treatment approach; however, drug-coated balloon angioplasty has emerged as a potential alternative strategy. This study aims to compare the clinical and angiographic outcomes of drug-coated balloon angioplasty versus drug-eluting stent implantation in patients undergoing percutaneous coronary intervention for chronic total occlusion. The study will include adult patients diagnosed with CTO who meet the predefined eligibility criteria. Outcomes related to procedural success and follow-up results will be evaluated to assess the effectiveness of both treatment strategies.
Trial Details
NCT Number NCT07369765
Lead Sponsor Biruni University
Conditions Coronary Artery Disease
Enrollment 200 participants
Start Date 2025-08-28
Primary Completion 2026-08-01 (estimated)
Study Completion 2027-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-27